GSK · GSK plc

Summary

Dodge & Cox disclosed a 4.93% voting rights position in GSK plc as of April 28, 2026, resulting from an acquisition or disposal of voting rights.

Key takeaways

• Dodge & Cox holds 4.93% of GSK plc voting rights, crossing a regulatory notification threshold.
• The position consists of 200,296,898 total voting rights held indirectly.
• The threshold was crossed on April 28, 2026, and GSK was notified on April 30, 2026.
• Holdings are split between Ordinary shares (2.19%) and ADRs (2.74%).